ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $21,457,000 | +8.9% | 1,358,056 | -12.5% | 0.81% | +2.4% |
| Q1 2018 | $19,709,000 | -0.5% | 1,551,873 | -10.3% | 0.79% | +3.5% |
| Q4 2017 | $19,809,000 | +2.4% | 1,730,028 | +9.6% | 0.76% | -3.0% |
| Q3 2017 | $19,336,000 | +41.5% | 1,578,477 | +32.2% | 0.79% | +37.8% |
| Q2 2017 | $13,668,000 | +9.2% | 1,193,672 | +98.3% | 0.57% | +11.1% |
| Q1 2017 | $12,518,000 | -1.9% | 601,832 | -1.9% | 0.51% | -5.5% |
| Q4 2016 | $12,755,000 | +116.3% | 613,232 | +159.6% | 0.54% | +91.5% |
| Q2 2016 | $5,898,000 | – | 236,193 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |